Browsing by Subject "KRN7000"
Now showing items 1-1 of 1
-
(Elsevier Ltd, 2018)© 2018 Elsevier Ltd Glycosylceramides that activate CD1d-restricted invariant natural killer T (iNKT) cells have potential therapeutic applications for augmenting immune responses against cancer and infections. Previous ...